HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jihui Jia Selected Research

Histone Demethylases

1/2018MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer.
1/2017Histone demethylase PHF8 promotes progression and metastasis of gastric cancer.
1/2016RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2.
7/2015Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit.
1/2015Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia.
4/2014Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis.
12/2013JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
1/2013Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212.
12/2011Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer.
3/2010The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jihui Jia Research Topics

Disease

34Stomach Neoplasms (Stomach Cancer)
11/2022 - 02/2008
32Neoplasms (Cancer)
04/2022 - 02/2008
17Carcinogenesis
01/2021 - 04/2009
12Infections
03/2021 - 04/2009
11Neoplasm Metastasis (Metastasis)
01/2019 - 01/2013
6Inflammation (Inflammations)
01/2019 - 11/2012
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 03/2010
3Gastritis
01/2019 - 10/2011
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2015 - 08/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Fatigue
12/2019
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2019
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2017
1Retinoblastoma (Glioblastoma, Retinal)
01/2016
1Premature Aging
12/2015
1Lung Diseases (Lung Disease)
12/2015
1Rhinitis
11/2015
1Allergic Rhinitis
11/2015
1Blast Crisis (Blast Phase)
01/2015
1Leukemia
01/2015
1Starvation
12/2013
1Breast Neoplasms (Breast Cancer)
10/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2013
1Pneumonia (Pneumonitis)
01/2013
1Melanoma (Melanoma, Malignant)
01/2013
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2012

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2008
10Histone DemethylasesIBA
01/2018 - 03/2010
7Messenger RNA (mRNA)IBA
03/2016 - 02/2008
6Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 02/2008
5Histones (Histone)IBA
12/2018 - 03/2010
4Sirtuin 1IBA
01/2021 - 12/2013
4Biological ProductsIBA
01/2020 - 03/2010
4CytokinesIBA
01/2019 - 11/2012
4MicroRNAs (MicroRNA)IBA
12/2016 - 08/2012
4Small Interfering RNA (siRNA)IBA
12/2013 - 05/2010
3Transcription Factors (Transcription Factor)IBA
01/2019 - 08/2009
3EnzymesIBA
07/2017 - 03/2010
3CateninsIBA
07/2017 - 12/2013
3telomerase RNA (bTR)IBA
12/2015 - 02/2008
2Circular RNAIBA
04/2022 - 11/2020
2Pharmaceutical PreparationsIBA
03/2021 - 01/2019
2Histone ChaperonesIBA
12/2018 - 07/2017
2Biomarkers (Surrogate Marker)IBA
01/2018 - 12/2012
2UbiquitinIBA
01/2018 - 11/2015
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2018 - 11/2015
2F-Box ProteinsIBA
01/2018 - 08/2014
2Cadherins (E-Cadherin)IBA
07/2015 - 01/2014
2Cyclin D1IBA
07/2014 - 12/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 01/2013
2VimentinIBA
04/2014 - 01/2014
2Oncogene Proteins (Oncogene Protein)IBA
08/2011 - 03/2010
1beta CateninIBA
11/2022
1Urea (Carbamide)FDA LinkGeneric
01/2021
1NF-kappa B (NF-kB)IBA
01/2021
1Histone-Lysine N-MethyltransferaseIBA
01/2021
1Member 2 Group A Nuclear Receptor Subfamily 4IBA
03/2020
1Phosphotransferases (Kinase)IBA
01/2020
1Prokaryotic Initiation Factor-3IBA
01/2019
1Eukaryotic Initiation Factor-3IBA
01/2019
1Verteporfin (Visudyne)FDA Link
01/2019
1Long Noncoding RNAIBA
01/2019
1Peptide Initiation Factors (Initiation Factor)IBA
01/2019
13' Untranslated Regions (3' UTR)IBA
01/2018
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2018
1ChromatinIBA
07/2017
1perfluorodecanoic acidIBA
01/2017
1InflammasomesIBA
01/2017
1Carboxylic AcidsIBA
01/2017
1mouse MIRN29 microRNAIBA
10/2016
1Indicators and Reagents (Reagents)IBA
03/2016
1Hepatocyte Nuclear FactorsIBA
03/2016
1Bortezomib (Velcade)FDA Link
11/2015
1OvalbuminIBA
11/2015
1Immunoglobulin E (IgE)IBA
11/2015
1Histamine (Histamine Dihydrochloride)FDA Link
11/2015
1CurcuminIBA
11/2015
1Anti-Allergic Agents (Antiallergic Agents)IBA
11/2015
1Lysine (L-Lysine)FDA Link
01/2015
1SKP Cullin F-Box Protein LigasesIBA
08/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2014
1SurvivinIBA
03/2014
1Apoptosis Regulatory ProteinsIBA
01/2014
1ProteomeIBA
12/2013
1Hormones (Hormone)IBA
10/2013
1Macrophage Colony-Stimulating FactorIBA
01/2013
1ResveratrolIBA
01/2013
1Retinoblastoma-Binding Protein 2IBA
01/2013
1Celecoxib (Celebrex)FDA Link
01/2013
1human MIRN212 microRNAIBA
01/2013
1Blood Proteins (Serum Proteins)IBA
12/2012
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
11/2012

Therapy/Procedure

7Therapeutics
01/2021 - 06/2012
5Drug Therapy (Chemotherapy)
11/2022 - 12/2012
1Immunotherapy
01/2021
1Injections
11/2020
1Kidney Transplantation
12/2019
1Home Nursing (Nursing, Home)
11/2019
1Adjuvant Chemotherapy
10/2013
1Lasers (Laser)
12/2012